Skip to main content
Michal M Achmatowicz on Muck Rack

Michal M Achmatowicz

San Diego
As seen in: ACS Publications, Royal Society of Chemistry
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michal M

Contact Michal M, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Development of an Improved Process To Prepare a Key Intermediate in the Manufacture of Sotorasib

|
By Kyle Quasdorf, Michal M Achmatowicz, Padmini Ananthoji, Joshua Bolger
| dx.doi.org
Open in Who Shared Issue with article?

Development of an Improved Process To Prepare a Key Intermediate in the Manufacture of Sotorasib

|
By Kyle Quasdorf, Michal M Achmatowicz, Padmini Ananthoji, Joshua Bolger
| ACS Publications
Open in Who Shared Issue with article?

Scalable Atroposelective Synthesis of MRTX1719: An Inhibitor of the PRMT5/MTA Complex

|
By Michal M Achmatowicz, Thomas Scattolin, David Snead, Dinesh J. Paymode
| dx.doi.org
MRTX1719 was identified as a potent inhibitor of the PRMT5/MTA complex, designed to selectively target MTAP-deleted cancers. A scalable synthesis of this atropisomeric compound and an efficient isolation of the desired isomer were required to support Phase 1 clinical trials, and this was established through further development of the racemic medicinal chemistry route.
Open in Who Shared Issue with article?
See all 4 articles